Here, we have identified RXFP1 as a new member of a growing number of GPCRs that utilize the JAK‐STAT signaling pathways previously associated with cytokine and growth factor receptor signaling during development, inflammation, and tumorigenesis [61, 79, 80], including glioma [81]. The gene discussed is SOAT1; the disease is central nervous system cancer.